Biomarkers Market Research Reports & Industry Analysis
Biomarkers are measurable indicators, such as molecules or genetic mutations, that provide information about a biological process, condition, or disease in the body. As healthcare evolves, it's important to grasp the impact and unique dynamics of this industry. At MarketResearch.com, we understand the need for reliable data on this sector. Our biomarkers market research reports provide a comprehensive and informative analysis, empowering you to navigate this dynamic industry with greater confidence.
Biomarkers Industry Insights
- Our research covers diverse markets so you can quickly and easily find research on segments big and small.
- Through our platform, you can access essential data to drive strategic decisions, from biomarkers market sizing and growth projections to key drivers and challenges.
- Use our research to better understand products under development, market trends, competitor analysis, and leading players.
Harnessing MarketResearch.com's Expertise
For more than twenty years, MarketResearch.com has been a leader in the field of market research, serving a diverse clientele that includes top investment banks, management consulting firms, and multinational corporations. We are known for providing reliable insights and offer a centralized platform with access to reports from numerous firms. In addition, our research specialists are available to provide expert guidance and support every step of the way.
Biomarkers Industry Research & Market Reports
-
In-vitro Diagnostics (IVD) Reagents Market - Global Outlook & Forecast 2025-2030
... discovery and companion diagnostics is reshaping the IVD reagents market. As personalized medicine continues to advance, the demand for high-quality reagents that enable precise biomarker detection and CDx assays is on the rise. Market players ... Read More
-
Renal Biomarkers Market Report by Biomarker Type (Functional Biomarker, Up-regulated Protein, and Others), Diagnostic Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), End User (Hospital, Diagnostic Laboratory, and Others), and Region 2025-2033
... The increasing public health concerns and its main risk factors, including hypertension, diabetes, and heart diseases, are bolstering the market. Renal biomarkers are cells, proteins, lipids, microRNAs, genes, metabolites, or proteomic patterns present on a ... Read More
-
In-vitro Colorectal Cancer Screening Tests Market Report by Product (Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests), Imaging Type (Colonoscopy, Proctoscopy, CT Scan, Ultrasound, MRI, PET Scan), End User (Hospitals, Clinics, Diagnostic Laboratories, and Others), and Region 2025-2033
... 4.96% during 2025-2033. In-vitro colorectal cancer screening tests are diagnostic procedures performed to detect adenomas, polyps and symptoms of colorectal cancer. Colorectal cancer refers to a medical condition that is characterized by the abnormal growth ... Read More
-
Precision Medicine Market By Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics) By Indication (Oncology, CNS, Immunology, Respiratory diseases, Genetic disorders, Skin diseases, Others) By Application (Diagnostics {Genetic Tests, Biomarker Based Tests, Esoteric Tests} Therapeutics {Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & anti-retroviral Drugs, Others) By End-user (Hospitals, Diagnostic Laboratories, Others) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
... Esoteric Tests} Therapeutics {Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & anti-retroviral Drugs, Others) By End-user (Hospitals, Diagnostic Laboratories, Others) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles ... Read More
-
U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Cancer Type, Application, End User, and Region - Analysis and Forecast, 2025-2035
... prostate cancer in the U.S. In addition, the focus of business leaders is establishing a deep understanding to address the unmet needs in clinical research to understand the U.S. prostate cancer testing market. Market Lifecycle ... Read More
-
Asia-Pacific Cancer Biomarker Testing Market Research Report by Type (Product and Services), by Testing Type (Single Gene Testing and Multiple Gene Testing), by Region (China, India, Japan, South Korea, Singapore, Australia, New Zealand, Hong Kong, Thailand, and Taiwan) Industry Forecast to 2032
... markers, such as molecules or genes, in blood, tissues, or other physiological fluids to ascertain the presence, progression, or risk of cancer. Early identification, diagnosis, prognosis, and treatment selection can be facilitated by these biomarkers, ... Read More
-
Ignite Biomedical Inc - Product Pipeline Analysis, 2024 Update
... data from complex non-linear systems which produces unbiased and accurate predictive algorithms. It is developing its biomarker blood test pipeline in therapeutic areas of rheumatoid arthritis, irritable bowel disease, and behavioral health. Ignite Biomedical is ... Read More
-
Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
... report by Grand View Research, Inc. Increased funding for R&D of neurological biomarkers to boost development of new drugs is expected to impel market growth. National Institute of Neurological Disorders and Stroke provides funding opportunities ... Read More
-
Patient Derived Xenograft / PDX Models
... reach US$1.0 Billion by 2030, growing at a CAGR of 14.3% over the analysis period 2024-2030. Mice PDX Models, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and ... Read More
-
Breast Cancer Liquid Biopsy
... 2030, growing at a CAGR of 21.9% over the analysis period 2024-2030. Reagent Kits, one of the segments analyzed in the report, is expected to record a 22.4% CAGR and reach US$819.3 Million by the ... Read More
-
2025 Global Genomics Biomarkers Market Industry (2031 Outlook)
... a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology analysis, ... Read More
-
Liquid Biopsy
... CAGR of 17.9% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$12.8 Billion by the end of the analysis ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.8 Billion While China is Forecast to Grow at 8.3% CAGR ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2025-2033
... rising prevalence of chronic diseases, ongoing developments in biotechnology and genomics, the shift toward personalized medicine, continuous advancements in analytical technologies, and increasing awareness among both healthcare professionals and patients about the benefits of biomarkers ... Read More
-
Biomarkers
... 13.7% over the analysis period 2024-2030. Safety, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$89.8 Billion by the end of the analysis period. Growth in ... Read More
-
Rare Biomarkers Specimen Collection and Stabilization
... reach US$87.8 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Circulating Cell Free DNA (ccfDNA), one of the segments analyzed in the report, is expected to record a 8.5% ... Read More
-
Cancer Biomarkers
... CAGR of 16.9% over the analysis period 2024-2030. Protein Biomarkers, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$42.9 Billion by the end of the analysis ... Read More
-
Tumor / Cancer Markers
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 10.4% CAGR The Tumor / Cancer Markers market ... Read More
-
Renal Biomarkers
... CAGR of 6.5% over the analysis period 2024-2030. Functional Biomarkers, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.1 Billion by the end of the analysis ... Read More
-
2025 Global Genomic Biomarkers Market Industry (2031 Outlook)
... a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology analysis, ... Read More
-
Genomic Cancer Testing Market, By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization, Microarray, Immunohistochemistry, Other genomic testing technologies), By End-User (Hospitals, Diagnostic Laboratories, Academic and Research Institutions, Cancer Centers, Other healthcare providers), By Biomarker Type (Genetic Biomarkers, Protein Biomarkers, Molecular Biomarkers, Epigenetic Biomarkers), By Service Provider (Diagnostic Laboratories, Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations), By Application (Targeted Therapy Selection, Disease Monitoring, Prognostic Testing, Companion Diagno
... tailor treatment based on an individual’s genetic profile and select therapeutics that directly target the abnormalities present. The genomic analysis of a tumor helps predict response to certain drugs, checks for genetic markers that may ... Read More
-
Genomic Cancer Panel and Profiling Market - A Global and Regional Analysis: Focus on Tissue Testing, Cancer Panel Type, Cancer Type, Application, Technology, End User, and Region - Analysis and Forecast, 2025-2035
... prevalence of cancer worldwide, coupled with the growing demand for personalized treatment approaches, has accelerated the adoption of genomic cancer panels for early diagnosis, prognosis, and therapy selection. According to the data published by the ... Read More
-
Biomarkers Market, By Product Type (Biomarkers Test Kits, Biomarker Analyzer), By Application (Diagnostic Biomarkers, Monitoring Biomarkers, Drug discovery and development, Predictive biomarkers, Prognostic biomarkers), By Disease Indication (Cancer, Cardiovascular disorders, Neurological Disorder, Infectious Disease, Others (Immunological Disorder, and Autoimmune Disorders among others )), By End User (Hospitals, Research laboratories, Diagnostic laboratories, Research and academic institute), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032
... blood, urine, or soft tissues. Numerous scientific disciplines employ biomarkers. There are 2 types of biomarkers actively used in the market, they are Biomarker test Kits and Biomarker Analyzer. A relatively new set of clinical ... Read More
-
Digital Biomarkers Market by Type of Product
... 18.48% during the forecast period, till 2035. The market opportunity for cell and gene therapy supply chain software has been distributed across the following segments: Type of Product Software / Applications Wearables Sensors Gaming Solutions ... Read More
Research Assistance
